NASDAQ
DTIL

Precision BioSciences Inc

(NO DISGNOSTIC SUBSTANCES)
LIFE SCIENCES

Prices are adjusted according to historical splits.

Precision BioSciences Inc Stock Price

Vitals

Today's Low:
$1.3600
Today's High:
$1.4500
Open Price:
$1.4200
52W Low:
$1.11
52W High:
$10.88
Prev. Close:
$1.4100
Volume:
624266

Company Statistics

Market Cap.:
$0.154 billion
Book Value:
0.93
Revenue TTM:
$0.038 billion
Operating Margin TTM:
-264.6%
Gross Profit TTM:
$0.116 billion
Gross Profit TTM:
$0.116 billion
Profit Margin:
-247.3%
Return on Assets TTM:
-23.5%
Return on Equity TTM:
-91.1%

Company Profile

Precision BioSciences Inc had its IPO on 2019-03-28 under the ticker symbol DTIL.

The company operates in the LIFE SCIENCES sector and (NO DISGNOSTIC SUBSTANCES) industry. Precision BioSciences Inc has a staff strength of 0 employees.

Stock update

Shares of Precision BioSciences Inc opened at $1.42 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $1.36 - $1.45, and closed at $1.39.

This is a -1.42% slip from the previous day's closing price.

A total volume of 624,266 shares were traded at the close of the day’s session.

In the last one week, shares of Precision BioSciences Inc have increased by +39%.

Precision BioSciences Inc's Key Ratios

Precision BioSciences Inc has a market cap of $0.154 billion, indicating a price to book ratio of 1.527 and a price to sales ratio of 4.106.

In the last 12-months Precision BioSciences Inc’s revenue was $0.038 billion with a gross profit of $0.116 billion and an EBITDA of $-0.091 billion. The EBITDA ratio measures Precision BioSciences Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Precision BioSciences Inc’s operating margin was -264.6% while its return on assets stood at -23.5% with a return of equity of -91.1%.

In Q2, Precision BioSciences Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 94.4%.

Precision BioSciences Inc’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
None

Its diluted EPS in the last 12-months stands at $-0.67 per share while it has a forward price to earnings multiple of - and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Precision BioSciences Inc’s profitability.

Precision BioSciences Inc stock is trading at a EV to sales ratio of 0.0292 and a EV to EBITDA ratio of -0.0132. Its price to sales ratio in the trailing 12-months stood at 4.106.

Precision BioSciences Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Precision BioSciences Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Precision BioSciences Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Precision BioSciences Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Precision BioSciences Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Precision BioSciences Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$1.39
52-Week High
$10.88
52-Week Low
$1.11
Analyst Target Price
$8.22

Precision BioSciences Inc stock is currently trading at $1.39 per share. It touched a 52-week high of $10.88 and a 52-week low of $10.88. Analysts tracking the stock have a 12-month average target price of $8.22.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Precision BioSciences Inc

The stock symbol (also called stock or share ticker) of Precision BioSciences Inc is DTIL

The IPO of Precision BioSciences Inc took place on 2019-03-28

Similar Industry Stocks ((NO DISGNOSTIC SUBSTANCES))

Last Price
Chg
Chg%
$12.02
0.16
+1.35%
$2.05
-0.01
-0.49%
$12.89
0.14
+1.1%
$4.26
-0.13
-2.96%
$15.21
-0.01
-0.07%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
$0.02
0.01
+100%
Oi S.A (OIBR-C)
$0
0
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Precision BioSciences, Inc., a genome editing company, develops therapeutic products in the United States. The company is headquartered in Durham, North Carolina.

Address

302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, US